Chantix Tablet, Film Coated
Product Images NDC 71205-381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 71205-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical Structure (Chantix 01)
Chemical structure diagram of varenicline tartrate, the active ingredient in CHANTIX 1 mg film-coated tablets by Proficient Rx LP. The diagram shows the molecular arrangement relevant to the prescription drug.*
FDA Label Image

Figure 1 (Chantix 02)

Figure 1 (Chantix 02)
A bar chart comparing the percentage outcomes of different studies evaluating CHANTIX (varenicline tartrate) 1 mg against placebo. The chart displays grouped bars for multiple studies, showing CHANTIX 1 mg, placebo, and other variables, with percentage values on the vertical axis and study numbers labeled on the horizontal axis. Error bars indicate variability for each group.*
FDA Label Image

Figure 2 (Chantix 03)

Figure 2 (Chantix 03)
A bar chart comparing efficacy outcomes of CHANTIX 1 mg tablets versus placebo and sustained-release bupropion (bupropion SR) across five clinical studies. The chart shows the percentage outcomes on the vertical axis with error bars for variability, illustrating differences among CHANTIX, bupropion SR, and placebo groups in smoking cessation efficacy.*
FDA Label Image

Figure 3 (Chantix 04)

Figure 3 (Chantix 04)
A line graph comparing the percentage of continuous abstinent participants over weeks of non-treatment follow-up for CHANTIX 1 mg BID and placebo groups. The x-axis represents weeks of non-treatment follow-up, and the y-axis shows the percentage of continuous abstinent subjects, illustrating a decline over time for both groups with CHANTIX maintaining higher abstinence rates.*
FDA Label Image

Logo (Chantix 05)

FDA Label Image

Logo (Chantix 06)

FDA Label Image

71205-381-56 (Chantix 12)

71205-381-56 (Chantix 12)
The packaging label for Chantix 1 mg film-coated tablets by Proficient Rx LP. The label indicates the product contains 56 tablets, each with 1 mg of varenicline tartrate (equivalent to 1 mg varenicline free base). The label includes storage instructions to keep the medication at 25°C (77°F) and to keep out of reach of children. The label also notes the product is for prescription use only and includes batch and lot number information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.